Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Gains from Sales and Divestitures (2010 - 2022)

Harte Hanks (HHS) reported Gains from Sales and Divestitures of $69110.0 for Q4 2022, up 1566.91% year-over-year from $4146.0 in Q4 2021, and up 1566.91% on a QoQ basis from $4146.0 in Q4 2021.

Harte Hanks (HHS) has 8 years of Gains from Sales and Divestitures data on file, last reported at $69110.0 in Q4 2022.

  • Quarterly Gains from Sales and Divestitures rose 1566.91% year-over-year to $69110.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $69110.0 (up 1566.91% YoY) and the FY2022 annual result came in at $69110.0, up 1566.91% from the prior year.
  • Gains from Sales and Divestitures advanced to $69110.0 in Q4 2022 per HHS's latest filing, from $4146.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $69110.0 in Q4 2022 and bottomed at $4146.0 in Q4 2021.
  • The 4-year median for Gains from Sales and Divestitures is $23945.0 (2019), against an average of $30286.5.
  • The widest annual swing landed in 2020, when Gains from Sales and Divestitures tumbled 79.85%; it then jumped 1566.91% in 2022.
  • Tracing HHS's Gains from Sales and Divestitures over 4 years: stood at $39858.0 in 2019, then plunged by 79.85% to $8032.0 in 2020, then slumped by 48.38% to $4146.0 in 2021, then jumped by 1566.91% to $69110.0 in 2022.
  • Per Business Quant, the three latest HHS Gains from Sales and Divestitures figures stand at $69110.0 (Q4 2022), $4146.0 (Q4 2021), and $8032.0 (Q4 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Honeywell International 149.73 Bn 138.42 Bn 3.54 Bn
2 3M 79.89 Bn 75.79 Bn 2.46 Bn
3 Valmont Industries 10.28 Bn 10.12 Bn 316.88 Mn
4 Seaboard 5.00 Bn 3.86 Bn 217.00 Mn
5 Otter Tail 3.50 Bn 3.10 Bn 239.49 Mn
6 Tetra Technologies 1.39 Bn 1.39 Bn 38.23 Mn
7 Deluxe 1.11 Bn 1.08 Bn 279.40 Mn
8 Matthews International 838.50 Mn 802.41 Mn 101.98 Mn
9 Compass Diversified Holdings 825.34 Mn 892.99 Mn 189.36 Mn
10 Harte Hanks 19.28 Mn 14.74 Mn 25.93 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 69,110.00
Dec 31, 2022 69,110.00
Dec 31, 2021 4,146.00
Dec 31, 2021 4,146.00
Dec 31, 2020 8,032.00
Dec 31, 2020 8,032.00
Dec 31, 2019 11,449.00
Dec 31, 2019 11,449.00
Dec 31, 2014 342,613.00
Dec 31, 2014 342,613.00
Dec 31, 2013 297,375.00
Dec 31, 2013 297,375.00
Dec 31, 2012 143,626.00
Dec 31, 2012 143,626.00
Dec 31, 2011 53,671.00
Dec 31, 2011 53,671.00
Dec 31, 2010 48,201.00
Dec 31, 2010 48,201.00